The Hospital Research Foundation Incorporated
Concentration RiskGiving Philosophy
THRF Group operates a multi-brand strategy with specialized charities focusing on specific diseases (breast cancer, prostate cancer, heart disease, kidney disease, Parkinson's, stroke, palliative care, arthritis) while maintaining a unified research support infrastructure. They fund both early-career and established researchers, provide conference travel support, and invest in translational research that moves from laboratory to clinical practice in partnership with public hospitals and research institutes.
Tips for Applicants
THRF Group uses SmartyGrants for applications. Conference support grants must be submitted in the appropriate round/cycle based on travel dates - check guidelines carefully for timing. Applications for Barry Marshall Awards must be submitted before travel commences. The foundation has strong ties to specific research institutes (Basil Hetzel Institute in SA) and Western Australian public health providers, so affiliation with these institutions is often required for eligibility. Contact grants@hospitalresearch.org.au with questions before applying.
Programs & Opportunities (3)
This program supports innovative research projects led by early-to-mid-career health and medical researchers from Eligible Administering Institutions in Western Australia. It focuses on advancing the treatment of cancer, mental health conditions, musculoskeletal conditions, cardiovascular, and neurodegenerative conditions using precision medicine approaches.
Travel awards up to $2,500 for WA-based health professionals and medical researchers to attend national or international scientific conferences between February 2026 and January 2027. Must be connected to a WA Public Health Service Provider.
Rolling grants for Basil Hetzel Institute-affiliated staff and HDR students: up to $750 for Australian or virtual conferences, up to $2,500 for international in-person conferences. Applications made after conference participation is completed.
Financial History (7 years)
| Year | Revenue | Expenses | Assets | Surplus |
|---|---|---|---|---|
| 2023 | $66.5M | $64.0M | $102.0M | $12.2M |
| 2022 | $66.5M | $60.6M | $81.9M | $5.8M |
| 2021 | $69.8M | $64.4M | $76.2M | $5.4M |
| 2020 | $66.7M | $59.0M | $73.2M | $9.2M |
| 2019 | $66.4M | $58.7M | $55.9M | $7.7M |
| 2018 | $56.3M | $49.0M | $41.0M | $7.3M |
| 2017 | $32.1M | $29.7M | $26.9M | $2.4M |
Community Evidence
External EvidenceIdentity
- GS ID
- AU-ABN-86248830078
- ABN
- 86248830078
- Sector
- indigenous
- Website
- www.hospitalresearch.org.au/
- Financial Year
- 2023
Focus Areas
Board & Leadership (13)
- board member
- board member
- board member
- board member
- board member
- board member
- chair
- director
- director
- director
- director
- director
- public officer
Financials
- Revenue
- $66.5M
- Assets
- $102.0M
Method
- Match Confidence
- registry
- Cross-references
- 2 datasets
- Match Key
- ABN
- Relationships
- 50
Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.
Data Sources
JusticeHub
External LinkThis entity is also tracked in JusticeHub with 0 interventions and 0 evidence records.
External ecosystem profile linked from GrantScope for additional context. JusticeHub content is maintained separately.
View on JusticeHubLocation Intelligence
- Postcode
- 5011
- Locality
- ST CLAIR
- Remoteness
- Major Cities of Australia
- SEIFA Disadvantage
- Decile 6/10
- LGA
- Charles Sturt
- SA2 Region
- Woodville - Cheltenham
- Entities in Area
- 144
Disability Market Context
NDIS LayerThis organisation shows disability-related delivery signals. The strategic question is whether it sits inside a resilient market, a thin market, or a captured market where large providers take most of the money and local alternatives are scarce.